Fort Washington Investment Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,300
| Closed | -$240K | – | 398 |
|
|
2024
Q4 | $240K | Hold |
1,300
| – | – | ﹤0.01% | 382 |
|
|
2024
Q3 | $256K | Hold |
1,300
| – | – | ﹤0.01% | 379 |
|
|
2024
Q2 | $269K | Buy |
1,300
+380
| +41% | +$78.5K | ﹤0.01% | 376 |
|
|
2024
Q1 | $249K | Buy |
920
+20
| +2% | +$5.42K | ﹤0.01% | 381 |
|
|
2023
Q4 | $213K | Buy |
+900
| New | +$213K | ﹤0.01% | 384 |
|
|
2022
Q2 | – | Sell |
-900
| Closed | -$256K | – | 425 |
|
|
2022
Q1 | $256K | Hold |
900
| – | – | ﹤0.01% | 479 |
|
|
2021
Q4 | $339K | Hold |
900
| – | – | ﹤0.01% | 458 |
|
|
2021
Q3 | $371K | Hold |
900
| – | – | ﹤0.01% | 434 |
|
|
2021
Q2 | $333K | Hold |
900
| – | – | ﹤0.01% | 444 |
|
|
2021
Q1 | $261K | Hold |
900
| – | – | ﹤0.01% | 461 |
|
|
2020
Q4 | $225K | Sell |
900
-900
| -50% | -$225K | ﹤0.01% | 476 |
|
|
2020
Q3 | $408K | Hold |
1,800
| – | – | ﹤0.01% | 389 |
|
|
2020
Q2 | $314K | Hold |
1,800
| – | – | ﹤0.01% | 426 |
|
|
2020
Q1 | $227K | Buy |
1,800
+100
| +6% | +$12.6K | ﹤0.01% | 403 |
|
|
2019
Q4 | $260K | Hold |
1,700
| – | – | ﹤0.01% | 455 |
|
|
2019
Q3 | $225K | Hold |
1,700
| – | – | ﹤0.01% | 476 |
|
|
2019
Q2 | $241K | Hold |
1,700
| – | – | ﹤0.01% | 478 |
|
|
2019
Q1 | $247K | Buy |
+1,700
| New | +$247K | ﹤0.01% | 477 |
|